These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4695951)

  • 1. Synergystic action of sera from transplant recipients and lymphocytes activated in vitro.
    Gordon J; MacDonald H; MacLean LD
    Transplant Proc; 1973 Mar; 5(1):429-31. PubMed ID: 4695951
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of soluble cytotoxins in cell-mediated immunity.
    Walker SM; Lucas ZJ
    Transplant Proc; 1973 Mar; 5(1):137-40. PubMed ID: 4572090
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody-dependent cell-mediated cytotoxicity in prospective kidney transplant recipients.
    Lightbody JJ; Rosenberg JC
    J Immunol; 1974 Mar; 112(3):890-6. PubMed ID: 4590706
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of cyclophosphamide on the rejection of allogenic rat kidney transplants. An in vitro study of cell-bound and antibody-mediated immunity.
    Husberg BS
    Clin Exp Immunol; 1972 Apr; 10(4):697-711. PubMed ID: 4556105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immune reactions in vitro: cytotoxicity of lymphocytes activated by phytohemagglutinin and anti-immunoglobulin serum.
    Resch K; Fischer H
    Eur J Immunol; 1971 Aug; 1(4):271-5. PubMed ID: 5316633
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro interaction of specifically-sensitized and non-sensitized lymphocytes with kidney cells from human renal homografts.
    Wolf JS; Fawley JC; Hume DM
    Transplant Proc; 1969 Mar; 1(1):328-30. PubMed ID: 4944237
    [No Abstract]   [Full Text] [Related]  

  • 7. Demonstration and identification of cytotoxic antibodies and antibodies blocking the cell-mediated antitumor immunity against adenovirus type 12-induced tumors.
    Ankerst J
    Cancer Res; 1971 Jul; 31(7):997-1003. PubMed ID: 4327089
    [No Abstract]   [Full Text] [Related]  

  • 8. in vitro quantitation of lymphocyte and serum cytotoxic activity following renal homograft rejection in man.
    Wolf JS; Fawley JC; Hume DM
    Transplant Proc; 1971 Mar; 3(1):449-52. PubMed ID: 4937916
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
    Rouse BT; Wagner H; Harris AW
    J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. I. Activation by tuberculin and by Staphylococcus filtrate.
    Stejskal V; Holm G; Perlmann P
    Cell Immunol; 1973 Jul; 8(1):71-81. PubMed ID: 4738316
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative in vitro assay of cytotoxic cellular immunity.
    Canty TG; Wunderlich JR
    J Natl Cancer Inst; 1970 Oct; 45(4):761-72. PubMed ID: 5513502
    [No Abstract]   [Full Text] [Related]  

  • 12. Specificity of destruction by lymphocytes activated in mixed leukocyte culture.
    Lightbody JJ; Bach FH
    Transplant Proc; 1972 Sep; 4(3):307-10. PubMed ID: 4263510
    [No Abstract]   [Full Text] [Related]  

  • 13. Temperature control of lymphocyte-mediated cytotoxicity in vitro.
    Berke G; Sullivan KA
    Transplant Proc; 1973 Mar; 5(1):421-3. PubMed ID: 4695950
    [No Abstract]   [Full Text] [Related]  

  • 14. Derect lymphocyte-mediated cytotoxicity as an assay of presensitisation.
    Garovoy MR; Franco V; Zschaeck D; Carpenter CB; Strom TB; Merrill JP
    Lancet; 1973 Mar; 1(7803):573-6. PubMed ID: 4120643
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative estimation of mouse transplantation antigens by two in vitro methods.
    Gyenes L; Bilimoria KM; Likhite V; Sehon AH
    Transplantation; 1972 Feb; 13(2):127-30. PubMed ID: 5059352
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell-mediated lympholysis in vitro with normal lymphocytes as target: specificity and cross-reactivity of the test.
    Miggiano VC; Bernoco D; Lightbody J; Trinchieri G; Ceppellini R
    Transplant Proc; 1972 Jun; 4(2):231-7. PubMed ID: 5034149
    [No Abstract]   [Full Text] [Related]  

  • 17. Passive antibody delays development of cell-mediated immunity in rats receiving renal allografts.
    Biesecker JL; Fitch FW; Rowley DA; Stuart FP
    Transplant Proc; 1973 Mar; 5(1):667-9. PubMed ID: 4572125
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytotoxicity of murine peritoneal macrophages in tumour allograft immunity.
    Den Otter W; Evans R; Alexander P
    Transplantation; 1972 Aug; 14(2):220-6. PubMed ID: 4114971
    [No Abstract]   [Full Text] [Related]  

  • 19. Allograft immunity in vitro. IV. Proliferative response and effector mechanism in mixed cultures of mouse blood lymphocytes.
    Häyry P; Virolainen M; Defendi V
    Transplant Proc; 1971 Mar; 3(1):876-8. PubMed ID: 5095894
    [No Abstract]   [Full Text] [Related]  

  • 20. Acceptance of phenotypically differing cultured skin in man and mice.
    Summerlin WT; Broutbar C; Foanes RB; Payne R; Stutman O; Hayflick L; Good RA
    Transplant Proc; 1973 Mar; 5(1):707-10. PubMed ID: 4633094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.